FPi Scientific office and plant profile
48
Future Pharmaceutical industries 1 Better Health …. Better Future Future
-
Upload
future-pharmaceuticals -
Category
Documents
-
view
393 -
download
9
Transcript of FPi Scientific office and plant profile
Future Pharmaceutical industries
1
Better Health …. Better Future
Future
Future
Future Quality 2
Future
Future Quality 3
Future Pharmaceutical industries "FPi“
•An Egyptian Pharmaceutical Company established in
accordance to investment Law "8" in March 2007,
With licensed purposes as follows:
Future
Future Quality
* Production of Pharmaceutical products (Human and Veterinary).
* Production of Pharmaceutical Packaging materials.
* Contract Manufacturing for other companies.
4
Future
Future Quality
* Toll Manufacturing at other companies.
* Purchasing, selling and distributing human and veterinary pharmaceutical products and food supplements.
* Export pharmaceutical products to all countries.
5
Future
Future Quality
* Research & Development of Pharmaceutical products and food supplements.
* Sales & Marketing National & International
* Finished Products Importation/
Distribution/
Selling/Promotion and Marketing.
6
Future
Future Quality
Licensed capital 150,000,000 L.E.
7
Future
Future Quality 8
March,11,2007 Company Legal establishment
April,15,2007 Site Land handover
Construction License
August 01,2008
Key Dates & Milestones
Future
Future Quality
∗ JuAugust 07,2011 ly,03,2008 August 07,2011
9
1st launch and Market introduction of the Company and
its products Jan 02,2012
MOH License to produce solid forms
1st day of actual execution at the site
August 7, 2011
August 1, 2008
Future
Future Quality 10
FPi Headcounts • Sales Teams 126 • Marketing & Business Development 8 • Medical , Training, Commercial and Tender 9 • Regulatory 3 •Administration 21 • Production 30 • Quality 28
Future
Future Quality
.
11
•Warehousing 12 •Engineering 10 •Finance 10 •Supply Chain & Purchasing 6 •Transportation 8
•Total 271
Future
Future Quality 12
FPi All current FPi products are generic and 100% owned by FPi.
FPi products portfolio (current and under registration)
covers all major therapeutic classes.
Anti-Rheumatic/ Analgesic products.
Antibiotics products.
GIT products.
Future
Future Quality
Cardiovascular Products.
CNS Products.
Ant diabetic Products
Respiratory, Antihistaminic .
Cold preparations.
13
Future
Future Quality 14
FPi 5 years business plan targeting market share of
1% by 2019.
FPi aims to be among Top Ten companies with market share of
3% by 2025
Future
Future Quality 15
Future Pharmaceutical industries
“FPi””
Scientific Office Sales & Marketing Arm
Technical Site
Future
Future Quality 16
Scientific Office Sales & Marketing
Arm
Future
Future Quality 17
Human Resources & Personnel Department.
3 Sales Lines according to Therapeutic Classes of different products and specialties of covered physicians with plan of adding other 3 Lines
in the coming 3 Years (2015-2017)
Marketing Department with 3 main divisions , one for each sales line with plan of adding other 3 divisions in the coming 3 Years (2015-2017)
Future
Future Quality 18
Medical Department , with Pharmacovigilance section.
Business Development Department
Export & International Marketing Department
Future
Future Quality 19
Commercial & Distribution Department.
Institutional & Tender Business Sales Department.
Regulatory Affairs & MOH Liaison Department.
Future
Future Quality 20
Training & Development Tender.
Legal Advisory .
Future
Future Quality 21
FPi Facility Technical Site
Future
Future Quality 22
•Location: plot 4G the extension, industrial zone #1 Badr City, 48 Km from Cairo center. • Plot Area: 16,400 M2 •1st Stage built area (Foot Print) 6,820 M2. •1st Stage built spaces: 18,205 M2. • Non sterile production block (current) 5,200 M2 •Warehousing (current) 2,000 M2
FPi Production Facilities
Future
Future Quality
•Quality and R&D (current) 1,000 M2 •Sterile Production area (extension) 2,000 M2 •Quality and R&D (extension) 3,000 M2 •Warehousing (extension) 1,500 M2 •Administration (1st & 2nd Floors) Current 1,450 M2 (3rd &4th Floors)(Extension) 1,450 M2 •Utility Block 510 M2 •Electricity & Security 95 M2
23
Future
Future Quality 24
• Dispensing area with 3 weighing Booths. • 2 granulation suits with 1 Technical Room. • 2 Blending rooms with 2 Quarantines. • 2 Compression Rooms with 1 Quarantines. • 2 Coating Rooms with1 Quarantines. • 2 Capsules Filling Rooms with 1 Quarantines. • 3 blistering Lines.
Non Sterile production Block
Future
Future Quality
• 1 Counting Room. • 1 sachet Filling Room. • 1 Solid Washing Dept. • 1 Central Packaging hall with 8 lines. • 4 Raw materials Day Stores. • 3 printing Rooms. • 1 folding Rooms . • 1 labeling Room • 2 offices. • 3 Tools Rooms. • 2 Liquid preparation areas. 2 liquid filling areas.
25
Future
Future Quality 26
• 1 semi-solid preparation area. • 1 semi-solid filling area. • Toilets Area. • Primary Change block & Lockers. • 5 Secondary Change Rooms. • 4 Technical Rooms. • 1 Engineering Room • Water Treatment Station. • Primary & Secondary passages.
Future
Future Quality 27
First Class most advanced production machines. Granulation Huttlin Germany Compression Korsch Germany Blending CMS France Coating Manesty England Capsule Filling Macofar Italy Blistering line Marchesini Italy Counting machine PharmaPack England
Production Machines
Future
Future Quality
Labeling machine CVC Taiwan Water Treatment Stilmas Italy Weighing Booths EMS USA Clean rooms partition, EasyPharma Italy Ceilings, doors, Windows, Hatches, Pass Boxes Balances Mettler
28
Future
Future Quality
Granulation 200 tons Blending 400 tons Compression 500 million Tab Encapsulation 150 millions Caps Coating 100 Tons Blistering 25 millions Blisters Storage 5000 pallets
29
Annual Production Capacity One Shift
Future
Future Quality
Liquid preparation 5 millions Liters Liquid filling 50 millions Bottles Semi-Solid preparation 100 Tons Semi-Solid Filling 5 millions Tubes
30
Annual Production Capacity One Shift
Future
Future Quality 31
Warehousing Raw Materials & Primary packaging Materials Warehouse.
Sampling Department, with weighing booth.
Quarantine
Cold Room Finished Products and Secondary Packaging materials warehouse with Quarantine & cold room. Two narrow aisle, high rise forklift from Yale , Italy
Future
Future Quality 32
Quality
Chemical Lab
Physical Lab
Microbiology lab
Instrument lab
Stability 3 Chambers
Future
Future Quality
R & D Suit
Quality Assurance Offices.
All quality instruments & equipments from Erweka
Germany,Water USA and Perken Elmer Germany
33
Future
Future Quality 34
Utility Block:
Two water Tanks
Boiler Station from Byworth England
Compressor station from Atlas Copco USA USA
Generator from Caterpillar Germany
3 chillers from carrier France
Future
Future Quality
HVAC Control System from Sauter Germany
Air Handling units from EGAT Egypt
Building Management System from Sauter Germany
35
Future
Future Quality 36
FPi has 45
products in different registration and R&D stages.
FPi already has 58 licensed
products.
FPi Products (Licensed & in pipeline)
Future
Future Quality
FPI Marketing Strategy
Ethical promotional activities with high frequency coverage on well selected targeted Doctors , pharmacies and hospitals. Quality is the success secret in all FPi activities.
37
Future
Future Quality 38
FPi Distribution Network: FPi Distributes through the major 5 Distributors in Egypt. • United Company for Pharmacists. UCP • Pharma Overseas. • Ibn Sina • Egyptian Drug trading Company EG Drug • Ramco.
Future
Future Quality
FPi Export Activity
•Fpi aims to be one of the greatest exporters in the world
39
Future
Future Quality
Latest Regulatory Inspection, and their current compliance status
40
Future
Future Quality 41
MOH inspectors regular visits to FPi
facility
EU-Pre assessment Audit Process from the Compliance Group UK
August 07,2011-MOH License to produce solid forms
Future
Future Quality 42
Sanofi
• 2 Days GMP Audit
Sandoz
• 2 Days GMP Audit
Novartis
• 2 Days GMP Audit
With Satisfactory Conclusion
Future
Future Quality 43
Tabuk
• 2 Days GMP Audit
Julphar
• 2 Days GMP Audit
Ranbaxy
• 2 Days GMP Audit
With Satisfactory Conclusion
Future
Future Quality
FPi is now qualified supplier for Novartis in Egypt
44
Product Name
Nu English Active Ingredient Dosage Form Theraputic class
1 Lanzofutal S.R 15 mg Lansoprazole 15 mg Pellets in hard gelatin capsules Proton pump inhibitors
2 Axin 150 mg Nizatidine 150 mg Hard Gelatin Capsules H2‐receptor antagonists
3 Gluokan 500/5 mg Metformin 500 mg + Glyburide 5
mgFilm coated tablets Ant diabetic drugs
4 Levocarnine 500 mg L‐carnitine L‐tartrate 736 mg Eq.
to L‐carnitine 500 mg Tablets Drugs used in metabolic disorders
5 Thionerv 300 mg Thioctic acid 300 mg Tablets For Neuropathies
6 Candalkan 4 mg Candesartan 4 mg Film Coated Tablets Antihypertensive ‐ Angiotensin‐II receptor antagonists
7 Candalkan 8 mg Candesartan 8 mg Film Coated Tablets Antihypertensive ‐ Angiotensin‐II receptor antagonists
8 Candalkan 16 mg Candesartan 16 mg Film Coated Tablets Antihypertensive ‐ Angiotensin‐II receptor antagonists
9 Candalkan Plus 16/12.5 Candesartan 16 mg + HCTZ 12.5 mg Film Coated Tablets Antihypertensive ‐ Angiotensin‐II receptor antagonists
10 Candalkan Plus 32/12.5 Candesartan 32 mg + HCTZ 12.5 mg Tablets Antihypertensive ‐ Angiotensin‐II receptor antagonists
11 Moflox 400mg Moxifloxacin Hydrochloride
436.37 mgFilm coated tablets Antibiotic ‐ Quinolones
12 Flamotal 400 mg Ibuprofen 400 mg Film coated tablets Non‐steroidal Anti‐inflammatory
13 Flamotal 600 mg Ibuprofen 600 mg Film coated tablets Non‐steroidal Anti‐inflammatory
14 Flamotal 800 mg Ibuprofen 800 mg Tablets Non‐steroidal Anti‐inflammatory
15 Ramazodef 400 mg Dexibuprofen 400 mg Film coated tablets Anti‐inflammatory
16 Quetapine 25 mg Quetiapine fumarate 28.78 mg Film coated tablets Atypical ‐ Antipsychotic agent
17 Quetiapine 100 mg Quetiapine fumarate 115.12 mg Film coated tablets Atypical ‐ Antipsychotic agent
18 Quetiapine 200 mg Quetiapine fumarate 230.24 mg Film coated tablets Atypical ‐ Antipsychotic agent
19 Futatreat 250 mg Levetiracetam 250 mg Film coated tablets Antiepileptic drug
20 Futatreat 500 mg Levetiracetam 250 mg Film coated tablets Antiepileptic drug
21 Futatreat 750 mg Levetiracetam 750 mg Film coated tablets Antiepileptic drug
22 Amitriptine 50 mg Amitriptyline HCL 55 mg Eq. to
Amitriptyline base 50 mg Tablets Antidepressant drugs
23 Exupar 15mg Buspirone 15mg Tablets Anxiolytics
24 Zodium 10 mg Zolpidem hemitartarate 10 mg Film coated tablets Hypnotics and anxiolytics
Fluoxetine Hydrochloride 22 4 mg25 Alzac 20 mg
Fluoxetine Hydrochloride 22.4 mg
Eq. to Fluoxetine base 20 mg Hard Gelatin Capsules Antidepressant drugs
26 Alzac 10 mg Fluoxetine Hydrochloride 11.2 mg
Eq. to Fluoxetine base 10 mg Hard Gelatin Capsules Antidepressant drugs
27 Histine 8 mg Betahistine dihydrochloride 8 mg Tablets Drugs used in nausea and vertigo
28 Histine 16 mg Betahistine dihydrochloride 16 mg Tablets Drugs used in nausea and vertigo
29 Histine 24 mg Betahistine dihydrochloride 24 mg Tablets Drugs used in nausea and vertigo29 Histine 24 mg Betahistine dihydrochloride 24 mg Tablets Drugs used in nausea and vertigo
30 Astin 20 mg Ebastine 20 mg Film Coated Tablets Anti – Histamine
31 Broncal 4 mg S.R Salbutamol Sulphate (Equivalent
to salbutamol base 4 mg)Hard Gelatin Capsules Anti‐cough
32 Broncal 8 mg S.R Salbutamol Sulphate (Equivalent
to salbutamol base 8 mg)Hard Gelatin Capsules Anti‐cough
to salbutamol base 8 mg)
33 Astin 10 mg Ebastine 10 mg Tablets Anti – Histamine
34 Risefutal 5 mg
Risedronate sodium 2.5 hydrate
5.73 mg Eq. to Risedronate
sodium 5 mg
Film Coated Tablets Drugs affecting bone metabolism
35 Levocarnine 1 gm / 10 ml L‐CARNITINE 1 gm / 10 ml Oral solution Drugs used in metabolic disorders
36 Mepram 1mg/ml Metoclopramide Hydrochloride 1
mg/ml Syrup Drugs used in nausea and vertigo
37 Zocef 125mg/5ml Cefuroxime Axetil 125 mg / 5 ml Dry powder for oral suspension Antibiotic ‐ Cephalosporins
38 Cefex 1 gm Cefadroxil 1gm Film coated tablets Antibiotic ‐ Cephalosporins
39 Doxcef 40mg/5ml Cefpodoxime proxetil 40 mg / 5 ml Dry powder for oral suspension Antibiotic ‐ Cephalosporins
40 Unimox 1gm Amoxycillin 1gm Film coated tablets Antibiotic ‐ Broad‐spectrum penicillins
41 Unimox 100mg/ml Amoxycillin 100 mg/ 1 ml Oral drops Antibiotic ‐ Broad‐spectrum penicillins
42 Flamotal 300 mg Ibuprofen 300 mg Suppository Non‐steroidal Anti‐inflammatory
43 Flamotal 500 mg Ibuprofen 500 mg Suppository Non‐steroidal Anti‐inflammatory
44 Flamotal 5% Ibuprofen 5% Gel Non‐steroidal Anti‐inflammatory
45 Flamotal 10% Ibuprofen10% Cream Non‐steroidal Anti‐inflammatory
46 Tri‐Broxol caps
Ambroxol +Guaphensin+
Theophylline 30 mg/100
mg/60 mg
Soft Gelatin Capsules Anti‐cough
47 Tri‐Broxol SyrupAmbroxol +Guaphensin+
Theophylline 0.3 g /0.6 g/1 gSyrup Anti‐cough
48 Broncoxil
Oxomemezine 0.033 gm
Paracetamol 0.666 mg
Guaiphenesin 0.666 gm
Sodium Benzoate
Syrup Anti‐cough
49 Astin Ebastine 5 mg / 5 ml Syrup Anti – Histamine
50 Virinotal Ribavirin 100mg / 5ml Syrup Antiviral
51 Aqua cream Aqua cream Cream Cosmetics preparations
52 Retro cream Retro cream Cream Cosmetics preparations
53 Lafamme Feminine cleanser Lafamme Feminine cleanser Soultion Cosmetics preparations
54 Belle cleanser Belle cleanser Solution Cosmetics preparations
Future
Future Quality
Thank You 45
